Anthrax Vaccine comment watch save
BreastfeedingGeriatricPediatric

  • TRADE NAMES: BioThrax (Emergent BioSolutions); Carbosap
  • INDICATIONS: Anthrax prophylaxis
  • CLASS: Vaccine
  • HALF-LIFE: Requires 1 month to achieve immunity (92.5% efficient)
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    Corticosteroids, Immunosuppressive therapies, Other vaccines

Dr. Sue Bailey, Assistant Secretary for Health Affairs, released a statement on June 29, 1999 that 'almost one million shots given, the anthrax immunization is proving to be one of the safest vaccination programs on record.' The ADRs reported occurred for '50 service members at one installation alone.' Note that no number of military personnel was mentioned at this installation, nor did it give any percentages for the reactions reported.

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric